141 related articles for article (PubMed ID: 35421767)
1. Diorganotin(IV) complexes based on tridentate ONO ligands as potential anticancer agents.
Jiang W; Qin Q; Xiao X; Tan Y
J Inorg Biochem; 2022 Jul; 232():111808. PubMed ID: 35421767
[TBL] [Abstract][Full Text] [Related]
2. Aroylhydrazone Diorganotin Complexes Causes DNA Damage and Apoptotic Cell Death: From Chemical Synthesis to Biochemical Effects.
Jiang W; Tan Y; Peng Y
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948323
[TBL] [Abstract][Full Text] [Related]
3. Diversity of complexes based on p-nitrobenzoylhydrazide, benzoylformic acid and diorganotin halides or oxides self-assemble: Cytotoxicity, the induction of apoptosis in cancer cells and DNA-binding properties.
Jiang W; Fan S; Zhou Q; Zhang F; Kuang D; Tan Y
Bioorg Chem; 2020 Jan; 94():103402. PubMed ID: 31718891
[TBL] [Abstract][Full Text] [Related]
4. Self-assembly synthesis of diorganotin complexes based on arylformylhydrazone possessing ONO donor set: anticancer activity and mechanism.
Jiang W; Zhang Z; Ni P; Tan Y
Metallomics; 2022 May; 14(5):. PubMed ID: 35556135
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, crystal structures, and biological activity of aroylhydrazone di-m-chlorobenzyltin complexes.
Jiang W; Zhou P; Chen L; Fu W; Tan Y
J Biol Inorg Chem; 2024 Feb; 29(1):87-99. PubMed ID: 38141090
[TBL] [Abstract][Full Text] [Related]
6. Diorganotin (IV) complexes with 4-nitro-N-phthaloyl-glycine: Synthesis, characterization, antitumor activity and DNA-binding studies.
Yan C; Zhang J; Liang T; Li Q
Biomed Pharmacother; 2015 Apr; 71():119-27. PubMed ID: 25960226
[TBL] [Abstract][Full Text] [Related]
7. Microwave-assisted synthesis of mixed ligands organotin(IV) complexes of 1,10-phenanthroline and l-proline: Physicochemical characterization, DFT calculations, chemotherapeutic potential validation by in vitro DNA binding and nuclease activity.
Nath M; Mridula ; Kumari R
J Photochem Photobiol B; 2017 Sep; 174():182-194. PubMed ID: 28780455
[TBL] [Abstract][Full Text] [Related]
8. Conventional and microwave-assisted synthesis, characterization, DFT calculations, in vitro DNA binding and cleavage studies of potential chemotherapeutic diorganotin(IV) mandelates.
Mridula ; Nath M
J Photochem Photobiol B; 2016 Sep; 162():348-360. PubMed ID: 27423117
[TBL] [Abstract][Full Text] [Related]
9. Spectroscopic characterizations, structural peculiarities, molecular docking study and evaluation of biological potential of newly designed organotin(IV) carboxylates.
Sirajuddin M; Ali S; McKee V; Akhtar N; Andleeb S; Wadood A
J Photochem Photobiol B; 2019 Aug; 197():111516. PubMed ID: 31170508
[TBL] [Abstract][Full Text] [Related]
10. Cell proliferation inhibition and antitumor activity of novel alkyl series of diorganotin(IV) compounds.
Koch B; Baul TS; Chatterjee A
J Appl Toxicol; 2008 May; 28(4):430-8. PubMed ID: 17668440
[TBL] [Abstract][Full Text] [Related]
11. Diorganotin(IV) derivatives of N-methyl p-fluorobenzo-hydroxamic acid: preparation, spectral characterization, X-ray diffraction studies and antitumor activity.
Naqeebullah ; Farina Y; Chan KM; Mun LK; Rajab NF; Ooi TC
Molecules; 2013 Jul; 18(7):8696-711. PubMed ID: 23881054
[TBL] [Abstract][Full Text] [Related]
12.
Yusof ENM; Latif MAM; Tahir MIM; Sakoff JA; Simone MI; Page AJ; Veerakumarasivam A; Tiekink ERT; Ravoof TBSA
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781445
[TBL] [Abstract][Full Text] [Related]
13. Polynuclear diorganotin(IV) complexes with arylhydroxamates: Syntheses, structures and in vitro cytotoxic activities.
Shang X; Cui J; Wu J; Pombeiro AJ; Li Q
J Inorg Biochem; 2008 Apr; 102(4):901-9. PubMed ID: 18234346
[TBL] [Abstract][Full Text] [Related]
14. Potentially bioactive organotin(IV) compounds: synthesis, characterization, in vitro bioactivities and interaction with SS-DNA.
Sirajuddin M; Ali S; McKee V; Sohail M; Pasha H
Eur J Med Chem; 2014 Sep; 84():343-63. PubMed ID: 25036793
[TBL] [Abstract][Full Text] [Related]
15. New Organotin (IV) Compounds Derived from Dehydroacetic Acid and Thiosemicarbazides: Synthesis, Rational Design, Cytotoxic Evaluation, and Molecular Docking Simulation.
Gómez E; Galván-Hidalgo JM; Pérez-Cuéllar G; Huerta-Landa KA; González-Hernández A; Gómez-García O; Andrade-Pavón D; Ramírez-Apan T; Rodríguez Hernández KD; Hernández S; Cano-Sánchez P; Gómez-Velasco H
Bioinorg Chem Appl; 2023; 2023():7901843. PubMed ID: 37920233
[TBL] [Abstract][Full Text] [Related]
16. Organotin derivatives of cholic acid induce apoptosis into breast cancer cells and interfere with mitochondrion; Synthesis, characterization and biological evaluation.
Stathopoulou MEK; Zoupanou N; Banti CN; Douvalis AP; Papachristodoulou C; Marousis KD; Spyroulias GA; Mavromoustakos T; Hadjikakou SK
Steroids; 2021 Mar; 167():108798. PubMed ID: 33472044
[TBL] [Abstract][Full Text] [Related]
17. Diorganotin(IV) derivatives of substituted benzohydroxamic acids with high antitumor activity.
Li Q; da Silva MF; Pombeiro AJ
Chemistry; 2004 Mar; 10(6):1456-62. PubMed ID: 15034889
[TBL] [Abstract][Full Text] [Related]
18. Syntheses, molecular structures, electrochemical behavior, theoretical study, and antitumor activities of organotin(IV) complexes containing 1-(4-chlorophenyl)-1-cyclopentanecarboxylato ligands.
Shang X; Meng X; Alegria EC; Li Q; Guedes da Silva MF; Kuznetsov ML; Pombeiro AJ
Inorg Chem; 2011 Sep; 50(17):8158-67. PubMed ID: 21793560
[TBL] [Abstract][Full Text] [Related]
19. Novel di-n-butyltin(IV) derivatives: Synthesis, high levels of cytotoxicity in tumor cells and the induction of apoptosis in KB cancer cells.
Shang X; Ding N; Xiang G
Eur J Med Chem; 2012 Feb; 48():305-12. PubMed ID: 22226547
[TBL] [Abstract][Full Text] [Related]
20. Macrocyclic diorganotin complexes of gamma-amino acid dithiocarbamates as hosts for ion-pair recognition.
Cruz-Huerta J; Carillo-Morales M; Santacruz-Juárez E; Hernández-Ahuactzi IF; Escalante-García J; Godoy-Alcantar C; Guerrero-Alvarez JA; Höpfl H; Morales-Rojas H; Sánchez M
Inorg Chem; 2008 Nov; 47(21):9874-85. PubMed ID: 18841933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
